These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 36170815)
1. Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer's models. Rangan P; Lobo F; Parrella E; Rochette N; Morselli M; Stephen TL; Cremonini AL; Tagliafico L; Persia A; Caffa I; Monacelli F; Odetti P; Bonfiglio T; Nencioni A; Pigliautile M; Boccardi V; Mecocci P; Pike CJ; Cohen P; LaDu MJ; Pellegrini M; Xia K; Tran K; Ann B; Chowdhury D; Longo VD Cell Rep; 2022 Sep; 40(13):111417. PubMed ID: 36170815 [TBL] [Abstract][Full Text] [Related]
2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression. Chen F; Yang D; Cheng XY; Yang H; Yang XH; Liu HT; Wang R; Zheng P; Yao Y; Li J Biol Pharm Bull; 2021 Nov; 44(11):1688-1696. PubMed ID: 34433707 [TBL] [Abstract][Full Text] [Related]
4. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model. Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145 [TBL] [Abstract][Full Text] [Related]
5. p47 Gong P; Chen YQ; Lin AH; Zhang HB; Zhang Y; Ye RD; Yu Y Alzheimers Res Ther; 2020 Nov; 12(1):146. PubMed ID: 33183342 [TBL] [Abstract][Full Text] [Related]
6. Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease. Duncan MJ; Guerriero LE; Kohler K; Beechem LE; Gillis BD; Salisbury F; Wessel C; Wang J; Sunderam S; Bachstetter AD; O'Hara BF; Murphy MP Neuroscience; 2022 Jan; 481():111-122. PubMed ID: 34856352 [TBL] [Abstract][Full Text] [Related]
7. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414 [TBL] [Abstract][Full Text] [Related]
8. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. Biyong EF; Tremblay C; Leclerc M; Caron V; Alfos S; Helbling JC; Rodriguez L; Pernet V; Bennett DA; Pallet V; Calon F Neurobiol Dis; 2021 Dec; 161():105542. PubMed ID: 34737043 [TBL] [Abstract][Full Text] [Related]
9. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. Belfiore R; Rodin A; Ferreira E; Velazquez R; Branca C; Caccamo A; Oddo S Aging Cell; 2019 Feb; 18(1):e12873. PubMed ID: 30488653 [TBL] [Abstract][Full Text] [Related]
10. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488 [TBL] [Abstract][Full Text] [Related]
11. Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice. Gao WR; Hu XH; Yu KY; Cai HY; Wang ZJ; Wang L; Wu MN Behav Brain Res; 2023 Feb; 438():114171. PubMed ID: 36280008 [TBL] [Abstract][Full Text] [Related]
12. Combined effects of aerobic exercise and 40-Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3×Tg mice. Park SS; Park HS; Kim CJ; Baek SS; Park SY; Anderson C; Kim MK; Park IR; Kim TW J Appl Physiol (1985); 2022 Apr; 132(4):1054-1068. PubMed ID: 35201933 [TBL] [Abstract][Full Text] [Related]
13. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models. Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997 [TBL] [Abstract][Full Text] [Related]
14. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice. Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Neuroinflammation Induced by Hyperphosphorylated Tau Protein Versus Ab42 in Alzheimer's Disease. Rice M; Nuovo GJ; Sawant D; Mishra A; Tili E Mol Neurobiol; 2024 Jul; 61(7):4589-4601. PubMed ID: 38105410 [TBL] [Abstract][Full Text] [Related]
16. GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer's disease mouse model. Park H; Kwon HS; Lee KY; Kim YE; Son JW; Choi NY; Lee EJ; Han MH; Park DW; Kim S; Koh SH Brain Behav Immun; 2024 Jan; 115():295-307. PubMed ID: 37884161 [TBL] [Abstract][Full Text] [Related]
17. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD). Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676 [TBL] [Abstract][Full Text] [Related]
18. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
19. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
20. Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice. Jagadeesan N; Roules GC; Chandrashekar DV; Yang J; Kolluru S; Sumbria RK J Transl Med; 2024 Mar; 22(1):291. PubMed ID: 38500108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]